ArticleHaematologica2024

A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia.

Guru Subramanian Guru Murthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.